Inventor
KEERTIKAR KARTIK M
US19 patents
⚠️ This page may combine multiple inventors who share the name “KEERTIKAR KARTIK M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
6 patentsUS7605155B2Oct 20, 2009
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
SCHERING CORP28 citations92
US6992080B2Jan 31, 2006
Imidazopyridines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations74
US7452902B2Nov 18, 2008
Imidazopyridines as cyclin dependent kinase inhibitors
SCHERING CORP2 citations63
US7342016B2Mar 11, 2008
Farnesyl protein transferase inhibitors as antitumor agents
SCHERING CORP5 citations61
US7807683B2Oct 5, 2010
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51
US7151104B2Dec 19, 2006
Pyrazolopyridines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations42
GUZI TIMOTHY J
3 patentsUS8586576B2Nov 19, 2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J15 citations91
US8580782B2Nov 12, 2013
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J14 citations83
US8673924B2Mar 18, 2014
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
GUZI TIMOTHY J11 citations81
MERCK SHARP & DOHME
3 patentsUS10138255B2Nov 27, 2018
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations50
US9840478B2Dec 12, 2017
Piperazine derivatives as HIV protease inhibitors
MERCK SHARP & DOHME1 citations48
US10646494B2May 12, 2020
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME0 citations41